Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-09-17

Clinical Trial Update: Safety and Efficacy of BMMNC in Multiple Sclerosis (MS) [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update examines the safety and efficacy of bone marrow mononuclear cells (BMMNC) in multiple sclerosis across Phase 1 and Phase 2, with curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bone Marrow Mononuclear Cells (bone marrow mononuclear cells)

Snippet

Sponsor: Chaitanya Hospital, Pune | Conditions: Multiple Sclerosis | Phase 1, Phase 2 | Status: UNKNOWN